17 Sep 2020

Palleon Pharmaceuticals secures $100m in Series B funding

Palleon Pharmaceuticals has raised $100m in a Series B financing round to develop drugs targeting glycan-mediated immune regulation to treat cancer and inflammatory diseases. The financing round, led by Matrix…